Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Giolito MV"'
Autor:
Głowacka K; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Ibanez S; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Renoult O; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Vermonden P; Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Louvain-la-Neuve, Belgium., Giolito MV; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Özkan K; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Degavre C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Aubert L; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Guilbaud C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Laloux-Morris F; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Richiardone E; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Ambroise J; Centre des Technologies Moléculaires Appliquées (CTMA), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Bouzin C; Imaging Platform 2IP, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Brusa D; CytoFlux-Flow Cytometry and Cell Sorting Platform, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Swinnen J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Corbet C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Larondelle Y; Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Louvain-la-Neuve, Belgium., Feron O; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium. olivier.feron@uclouvain.be.; Walloon Excellence in Life Sciences and BIOtechnology (WELBIO) Department, WEL Research Institute, Wavre, Belgium. olivier.feron@uclouvain.be.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 21; Vol. 15 (1), pp. 10107. Date of Electronic Publication: 2024 Nov 21.
Autor:
Richiardone E; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium., Al Roumi R; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium., Lardinois F; Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium., Giolito MV; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium., Ambroise J; Centre des Technologies Moléculaires Appliquées (CTMA), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 54, B-1200, Brussels, Belgium., Boidot R; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center-UNICANCER, 21079, Dijon, France., Drotleff B; Metabolomics Core Facility, EMBL Heidelberg, Heidelberg, Germany., Ghesquière B; Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; Metabolomics Core Facility Leuven, Center for Cancer Biology, VIB, Leuven, Belgium., Bellahcène A; Metastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium., Bardelli A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy., Arena S; Department of Oncology, University of Torino, Candiolo, TO, Italy; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, TO, Italy. Electronic address: sabrina.arena@unito.it., Corbet C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium. Electronic address: cyril.corbet@uclouvain.be.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217091. Date of Electronic Publication: 2024 Jul 02.
Autor:
Giolito MV; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France.; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Experimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium., Bodoirat S; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France., La Rosa T; Stem-Cell and Brain Research Institute, U1208 INSERM, USC1361 INRA, 69675, Bron, France., Reslinger M; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France.; Université de Strasbourg, CNRS, INSERM, IGBMC UMR 7104-UMR-S 1258, Illkirch, France., Guardia GDA; Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil., Mourtada J; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France., Claret L; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France.; Université de Strasbourg, CNRS, INSERM, IGBMC UMR 7104-UMR-S 1258, Illkirch, France., Joung A; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France.; Laboratoire de Biologie Tumorale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Galante PAF; Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil., Penalva LOF; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Plateroti M; Université de Strasbourg, INSERM, IRFAC/UMR-S1113, FMTS, 67200, Strasbourg, France. michelina.plateroti@igbmc.fr.; Université de Strasbourg, CNRS, INSERM, IGBMC UMR 7104-UMR-S 1258, Illkirch, France. michelina.plateroti@igbmc.fr.
Publikováno v:
Cell death & disease [Cell Death Dis] 2024 May 01; Vol. 15 (5), pp. 306. Date of Electronic Publication: 2024 May 01.
Autor:
Cornista AM; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida., Giolito MV; Department of Biomedical Sciences, Vrije Universiteit Brussel, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., Baker K; Department of Oncology, University of Alberta, Edmonton, Canada.; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada., Hazime H; Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida., Dufait I; Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Datta J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Division of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida., Khumukcham SS; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina.; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., De Ridder M; Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Roper J; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina.; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina., Abreu MT; Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Breckpot K; Department of Biomedical Sciences, Vrije Universiteit Brussel, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., Van der Jeught K; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Gastro hep advances [Gastro Hep Adv] 2023; Vol. 2 (8), pp. 1103-1119. Date of Electronic Publication: 2023 Sep 19.
Autor:
Morris ME; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA. Electronic address: memorris@buffalo.edu., Ren T; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA., Asare-Nkansah S; Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Bilensoy E; Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Turkey., Gatwood J; Department of Clinical Pharmacy and Translational Science, The University of Tennessee Health Science Center, USA., Giolito MV; UMR-S1113 - IRFAC - INSERM, Strasbourg, France., Nicolazzo JA; Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia., Zuo Z; School of Pharmacy, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong., Pauletti GM; St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in St. Louis, St. Louis, Missouri, USA; International Pharmaceutical Federation, The Hague, Netherlands.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Dec; Vol. 111 (12), pp. 3196-3205. Date of Electronic Publication: 2022 Jul 13.
Autor:
Giolito MV; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France.; INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, France., La Rosa T; INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, France., Farhat D; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France.; INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, France., Bodoirat S; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France., Guardia GDA; Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil., Domon-Dell C; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France., Galante PAF; Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil., Freund JN; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France., Plateroti M; Inserm, IRFAC/UMR-S1113, FMTS, Université de Strasbourg, France.; INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, France.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Dec; Vol. 16 (22), pp. 3975-3993. Date of Electronic Publication: 2022 Oct 10.
Autor:
Morris ME; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA. Electronic address: memorris@buffalo.edu., Ren T; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA., Asare-Nkansah S; Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Bilensoy E; Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Turkey., Gatwood J; Department of Clinical Pharmacy and Translational Science, The University of Tennessee Health Science Center, USA., Giolito MV; UMR-S1113 - IRFAC - INSERM, Strasbourg, France., Nicolazzo JA; Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia., Zuo Z; School of Pharmacy, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong., Pauletti GM; St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in St. Louis, St. Louis, Missouri, USA; International Pharmaceutical Federation, The Hague, the Netherlands.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Dec; Vol. 111 (12), pp. 3206-3214. Date of Electronic Publication: 2022 Jul 14.
Autor:
Giolito MV; Université de Strasbourg, Inserm, IRFAC/UMR-S1113, FMTS, 3 Avenue Molière 67200, Strasbourg, France., Plateroti M; Université de Strasbourg, Inserm, IRFAC/UMR-S1113, FMTS, 3 Avenue Molière 67200, Strasbourg, France. plateroti@unistra.fr.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2022 Aug 10; Vol. 79 (9), pp. 476. Date of Electronic Publication: 2022 Aug 10.
Autor:
Godart M; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Frau C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Farhat D; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Giolito MV; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Jamard C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Le Nevé C; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France., Freund JN; Université de Strasbourg, Inserm, IRFAC/UMR-S1113, FMTS, 67200 Strasbourg, France., Penalva LO; Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Sirakov M; Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Napoli, Italy., Plateroti M; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, Département de la recherche, 69000 Lyon, France.
Publikováno v:
Development (Cambridge, England) [Development] 2021 Apr 15; Vol. 148 (8). Date of Electronic Publication: 2021 Apr 20.
Autor:
Giolito MV; Département de la recherche, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard; UMR-S1113 - IRFAC INSERM, Université de Strasbourg., Claret L; Département de la recherche, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard; UMR-S1113 - IRFAC INSERM, Université de Strasbourg., Frau C; Département de la recherche, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard., Plateroti M; Département de la recherche, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard; UMR-S1113 - IRFAC INSERM, Université de Strasbourg; plateroti@unistra.fr.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2021 Jan 22 (167). Date of Electronic Publication: 2021 Jan 22.